|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
The Lancet: Toward better control of
colorectal cancer. Lancet. 383:14372014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao
X: Long noncoding RNAs: Novel players in colorectal cancer. Cancer
Lett. 361:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hua F, Liu S, Zhu L, Ma N, Jiang S and
Yang J: Highly expressed long non-coding RNA NNT-AS1 promotes cell
proliferation and invasion through Wnt/β-catenin signaling pathway
in cervical cancer. Biomed Pharmacother. 92:1128–1134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang Q, Wang S, Li X, Yang F, Feng C,
Zhong K, Qiu M and Wang J: Circular RNA ATXN7 is upregulated in
non-small cell lung cancer and promotes disease progression. Oncol
Lett. 17:4803–4810. 2019.PubMed/NCBI
|
|
10
|
Wang L, Ma H, Kong W, Liu B and Zhang X:
Up-regulated circular RNA VANGL1 contributes to progression of
non-small cell lung cancer through inhibition of miR-195 and
activation of Bcl-2. Biosci Rep. 39:BSR201824332019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He W, Zhang Y and Xia S: LncRNA NNT-AS1
promotes non-small cell lung cancer progression through regulating
miR-22-3p/YAP1 axis. Thorac Cancer. 11:549–560. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Yang L, Hu X, Jiang Y, Hu Y, Liu
Z, Liu J, Wen T, Ma Y, An G and Feng G: Upregulated NNT-AS1, a long
noncoding RNA, contributes to proliferation and migration of
colorectal cancer cells in vitro and in vivo. Oncotarget.
8:3441–3453. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun T, Kalionis B, Lv G, Xia S and Gao W:
Role of exosomal noncoding RNAs in lung carcinogenesis. Biomed Res
Int. 2015:1258072015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gallo A, Tandon M, Alevizos I and Illei
GG: The majority of microRNAs detectable in serum and saliva is
concentrated in exosomes. PLoS One. 7:e306792012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luga V, Zhang L, Viloria-Petit AM,
Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and
Wrana JL: Exosomes mediate stromal mobilization of autocrine
Wnt-PCP signaling in breast cancer cell migration. Cell.
151:1542–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hewson C and Morris KV: Form and function
of exosome-associated long non-coding RNAs in cancer. Curr Top
Microbiol Immunol. 394:41–56. 2016.PubMed/NCBI
|
|
17
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma R, Zhu P, Liu S, Gao B and Wang W:
MiR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt
signaling pathway in non-small cell lung cancer. Biochem Biophys
Res Commun. 518:273–277. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alvarado S, Wyglinski J, Suderman M,
Andrews SA and Szyf M: Methylated DNA binding domain protein 2
(MBD2) coordinately silences gene expression through activation of
the microRNA hsa-mir-496 promoter in breast cancer cell line. PLoS
One. 8:e740092013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J, Du W, Wang X, Wei L, Pan Y, Wu X,
Zhang J and Pei D: Ras-related protein Rap2c promotes the migration
and invasion of human osteosarcoma cells. Oncol Lett. 15:5352–5358.
2018.PubMed/NCBI
|
|
21
|
Zhu X, Qiu J, Zhang T, Yang Y, Guo S, Li
T, Jiang K, Zahoor A, Deng G and Qiu C: MicroRNA-188-5p promotes
apoptosis and inhibits cell proliferation of breast cancer cells
via the MAPK signaling pathway by targeting Rap2c. J Cell Physiol.
235:2389–2402. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Huang C, Zhang A, Lu C and Liu L:
Overexpression of circRNA_100290 promotes the progression of
laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C
axis. Biomed Pharmacother. 125:1098742020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu R, Yu BX, Chen JF, Lv XY, Yan ZJ, Cheng
Y and Ma Q: Anti-tumor effects of Atractylenolide I on bladder
cancer cells. J Exp Clin Cancer Res. 35:402016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muschelli J: ROC and AUC with a binary
predictor: Potentially a misleading metric. J Classif. 37:696–708.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Zhang S, Qiu T, Wang Y, Ricketts DM
and Qi C: Upregulation of long non-coding RNA NNT-AS1 promotes
osteosarcoma progression by inhibiting the tumor suppressive
miR-320a. Cancer Biol Ther. 20:413–422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li T, Ding ZL, Zheng YL and Wang W:
MiR-484 promotes non-small-cell lung cancer (NSCLC) progression
through inhibiting Apaf-1 associated with the suppression of
apoptosis. Biomed Pharmacother. 96:153–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang L, Duan W, Yan S, Xie Y and Wang C:
Circulating long non-coding RNA colon cancer-associated transcript
2 protected by exosome as a potential biomarker for colorectal
cancer. Biomed Pharmacother. 113:1087582019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu YB, Jiang Q, Yang MY, Zhou JX and Zhang
Q: Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma
progression and metastasis through miR-363/CDK6 axis. Oncotarget.
8:88804–88814. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang Y, Shi J and Xu Y: Long non-coding
RNA NNT-AS1 contributes to cell proliferation, metastasis and
apoptosis in human ovarian cancer. Oncol Lett. 15:9264–9270.
2018.PubMed/NCBI
|
|
31
|
Abedini P, Fattahi A, Agah S, Talebi A,
Beygi AH, Amini SM, Mirzaei A and Akbari A: Expression analysis of
circulating plasma long noncoding RNAs in colorectal cancer: The
relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
J Cell Physiol. 234:22028–22033. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen J, Hodges TR, Song R, Gong Y, Calin
GA, Heimberger AB and Zhao H: Serum HOTAIR and GAS5 levels as
predictors of survival in patients with glioblastoma. Mol Carcinog.
57:137–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
35
|
Niu L, Song X, Wang N, Xue L, Song X and
Xie L: Tumor-derived exosomal proteins as diagnostic biomarkers in
non-small cell lung cancer. Cancer Sci. 110:433–442. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pant S, Hilton H and Burczynski ME: The
multifaceted exosome: Biogenesis, role in normal and aberrant
cellular function and frontiers for pharmacological and biomarker
opportunities. Biochem Pharmacol. 83:1484–1494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou R, Chen KK, Zhang J, Xiao B, Huang Z,
Ju C, Sun J, Zhang F, Lv XB and Huang G: The decade of exosomal
long RNA species: An emerging cancer antagonist. Mol Cancer.
17:752018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu T, Zhang X, Gao S, Jing F, Yang Y, Du
L, Zheng G, Li P, Li C and Wang C: Exosomal long noncoding RNA
CRNDE-h as a novel serum-based biomarker for diagnosis and
prognosis of colorectal cancer. Oncotarget. 7:85551–85563. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qi NN, Tian S, Li X, Wang FL and Liu B:
Up-regulation of microRNA-496 suppresses proliferation, invasion,
migration and in vivo tumorigenicity of human osteosarcoma cells by
targeting eIF4E. Biochimie. 163:1–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ye J, Xie W, Zuo Y, Jing G and Tong J:
MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF
in osteosarcoma. Exp Ther Med. 19:1425–1431. 2020.PubMed/NCBI
|
|
41
|
Wang H, Yan B, Zhang P, Liu S, Li Q, Yang
J, Yang F and Chen E: MiR-496 promotes migration and
epithelial-mesenchymal transition by targeting RASSF6 in colorectal
cancer. J Cell Physiol. 235:1469–1479. 2020. View Article : Google Scholar : PubMed/NCBI
|
